SEARCH BY NAME

BROWSE

Browse Australian delisted companies

0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Browse terminated Australian managed funds

0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
SEARCH BY CODE

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

CHAPMANS LIMITED (CHP)

SHARE PRICES

(updated at weekends)

Former (or subsequent) names

 

Shareholder links

Our website ranking of CHP: rating 2
(2 out of 5)
COMPANY WEBSITE:

 

REGISTRY:
Automic Registry Services LEVEL 2, 267 St Georges Terrace,, PERTH, WA, AUSTRALIA, 6000
Tel : +61 (2) 8072 1400 or 1300 288 664 (within Australia)
RegistryWebsite RegistryEmail

Company details

ISIN: AU000000CHP2
Address: Level 12, 95 Pitt Street Sydney NSW 2000
Tel:  +61 2 8079 2939 Fax: 02 9300 3677

Date first listed: 28/07/1971
Company Secretary: Peter Dykes
Sector: Diversified Financials
Industry Group: XFJ
Activities: General and share investment and evaluation of property investment projects
OFX Transferring Money Internationally to Free

Shareholders in this company should consider crystallising a capital loss in 2020/21 by selling their worthless shares, which they can achieve online by entering transaction details here. While this usually makes good economic sense, we recommend you seek professional advice before buying or selling securities, your accountant is probably the best person.

13/08/2020

delisted from the close of trading on Monday, 29 April 2019 pursuant to Listing rule 17.11.

29/04/2019

we understand the company delisted from ASX because of the financial burden of the listing fees and compliance costs, delays in implementing company objectives because of regulatory obstacles in the ASX listing rules and the share price did not reflect true value

29/04/2019

The company releases the results of its meeting.

27/03/2019

The company has today issued a further 47,000,000 fully paid ordinary shares at a $0.005 per share, being the price at which shares were offered under the rights issue announced on 28 November 2018. The new shares comprise the placement of the remaining balance of the shortfall arising under the rights issue. The new shares were issued to third party sophisticated and professional investors.

15/03/2019

The company releases a notice of EGM. The meeting will be held on 27 March 2019 at 10.00am (AEDT) at Thomson Geer, Level 25, 1 O'Connell Street, Sydney NSW 2000.

22/02/2019

Following a resolution of the board, the company submitted a formal application for the removal of the company from the official list of the ASX. The Company has obtained in-principle advice from the ASX in relation to the delisting. The ASX has confirmed that upon receipt of a formal request to delist, it is likely to remove the Company from the Official List of the ASX, subject to the Company complying with certain conditions of which the Company intends to fully comply with.

22/02/2019

The company lodges its Appendix 4C - quarterly.

01/02/2019

The company issues a response to ASX Query Letter.

29/01/2019

Chapmans has been informed by the directors of 20FOUR that 20FOUR appointed Roger Grant from Dye and Co. as an external controller on Friday 21st December and went into liquidation the same day.

31/12/2018

The company releases ASX Query Letter re ADP Capital Sdn Bhd (ADP)

24/12/2018

The company releases Notification of Shortfall

19/12/2018

The securities of Chapmans Limited will be suspended from quotation immediately under Listing Rule 17.3, pending further enquiries by ASX Limited.

07/12/2018

we understand that on or about this date the company consolidated its shares 1 for 10

02/11/2018

The suspension of trading in the securities of Chapmans Limited will be lifted immediately in accordance with Listing Rule 17.7, following the release by the Company of a cleansing prospectus pursuant to section 708A(11) of the Corporations Act.

16/04/2018

The company issues a prospectus for the conditional offer of 1,000 Shares at an issue price of $0.01 each to raise $10. This Prospectus has also been prepared primarily for the purposes of section 708A(11) of the Corporations Act to remove any trading restrictions on the sale of certain Shares issued prior to the Closing Date.

16/04/2018

Chapmans and GPU.One have executed an amended term sheet for a reduced investment by Chapmans in GPU.One. Chapmans has received clearance from the ASX to proceed with the investment subject to binding documentation being executed. Chapmans will raise approximately AUD$4.552 million for the GPU.One investment and working capital. Chapmans' directors will invest a further AUD$750,000 on the same terms subject to shareholder approval. GPU.One is an established and profitable data processing and cryptocurrency mining company based in Canada.

16/04/2018

The company issues a response to ASX Query Letter.

12/04/2018

The company has amended its GPU.One presentation. The amendments have been made to clarify that GPU.One currently occupies and operates Facility 1 "“ Mirabel. Facility 2 "“ Saguenay is a facility which is not currently occupied by GPU.One, however, GPU.One has an option to purchase Facility 2 "“ Saguenay and so it is included in the presentation as an additional facility which GPU.One proposes to occupy.

10/04/2018

The company provides an update in respect of its investment in Securrency. Chapmans has decided to not proceed with the second US$1m tranche based on Securrency's execution plans to list on the TSX not proceeding to the satisfaction of Chapmans as at 31 March, 2018. Notwithstanding the Company's decision to not proceed with the second US$1m tranche, Chapmans retains its rights to invest a further US$2m in Securrency in US$1m tranches on or before 30 April and 31 May, 2018.

05/04/2018

The company releases an Appendix 4G.

03/04/2018

The company releases its Corporate Governance Statement.

03/04/2018

The company lodges its Annual Report to shareholders.

03/04/2018

The securities of Chapmans Limited will be suspended from official quotation in accordance with Listing Rule 17.3 pending enquiries by ASX into the matters disclosed in the Company's announcement dated 26 March 2018.

26/03/2018

The suspension of trading in the securities of Chapmans Limited will be lifted immediately, following lodgement of announcements in relation to the completion of a capital raising and the Company's proposed transaction with Securrency, Inc.

09/02/2018

The company has completed the placement to raise $1,050,000 via the issue of 70M shares at $0.015. The Company will issue the first 25M shares under its Listing Rule 7.1 capacity with the remainder to be issued subject to shareholder approval at a future general meeting, the timing of which is not yet known. The funds will be used for working capital and as part of the investment in Securrency.

09/02/2018

The company has entered into a binding term sheet to invest US$4 million in the leading US-based blockchain finance and trading platform, Securrency, Inc.

09/02/2018

The securities of Chapmans Limited will be suspended from quotation immediately under listing rule 17.2, at the request of the Company, pending the release of an announcement in relation to a potential investment and details of a capital raising.

07/02/2018

The suspension of trading in the securities of Chapmans Limited will be lifted from the commencement of trading on Wednesday, 6 September 2017, in accordance with listing rule 17.8, following lodgement of the Company's Half Yearly Report and Accounts for the period ended 30 June 2017.

05/09/2017

The company lodges its Half Year Accounts.

05/09/2017

The company will be suspended from official quotation from the commencement of trading today, 1 September 2017 following failure to lodge either its Preliminary Final Report or Half Year Report and Accounts for the period ended 30 June 2017 in accordance with ASX Listing Rules.

01/09/2017

we understand that on or about this date the company consolidated its shares 1 for 10

30/12/2016

The suspension of trading in the securities of Chapmans Limited will be lifted from the commencement of trading on Monday, 26 September 2016, in accordance with listing rule 17.8, following lodgement of the Company's Half Yearly Report and Accounts for the period ended 30 June 2016.

23/09/2016

The company lodges its half year accounts.

23/09/2016

The company lodges its half year results update.

16/09/2016

The planned release of the Half Year Results has been further delayed. The delay has been caused by the adoption of a new accounting policy, whereby CHP will be considered an investment entity for the purposes of the accounting standards. As a result, the Half Year results will not be released until mid to late next week.

12/09/2016

The securities of the company will be suspended from Official Quotation from the commencement of trading today, 1 September 2016 following failure to lodge their Half Yearly Report and Accounts for the period ended 30 June 2016, in accordance with ASX Listing Rules.

01/09/2016

we understand that on or about this date the company consolidated its shares 1 for 10

11/08/2014

listed entity carried for record purposes only

01/07/2004

ASX Announcements (courtesy of ASX)

 

Your comments

Please read our Terms before viewing comments.
Loading comments....  Most recent comments

Apologies  -  that was what the Delisted link have me. 

The following gets through to what I think is their website:

www.chapmanslimited.com

Still not sure how I can sell my shares.

10/08/2020 16:28:52

What is it with their website  -  now some sort of Chinese gambling site??

What is going on?

 

10/08/2020 16:23:09

Disgusting, I feel like I\'ve been robbed

23/03/2020 08:17:53

I feel like I\'ve been robbed

10/05/2019 10:24:40

I\'m an investor of Chapmans Ltd but unfortunately I did not do my research before investing. I had read an article on a website saying that Chapmans Ltd had invested in MJLS \"MJ Life Sciences\" :

\"MJLS is an Australian special-purpose company established with the aim of becoming a leading global medicinal cannabis holding and investment company.

It is also a direct investor in Caziwell Inc., owner of the established North American medicinal cannabis brand and business, Aunt Zelda’s, with convertible note rights of up to 49.99% in Caziwell Inc.\"

However there is no website for MJ Life Sciences Pty Ltd. The nearest info I found was from S&P Global Market Intelligence which states that : \"MJ Life Sciences Pty Ltd is a holding company. The company, through its subsidiaries, produces medical cannabis. MJ Life Sciences Pty Ltd was incorporated in 2015 and is based in West Perth, Australia\" And \"MJ Life Sciences Pty Ltd does not have any Key Executives recorded\". Also \"No transactions available in the past 12 months\".

Also I couldn\'t find any information about half of the 6 companies Chapmans claim to have invested in on their website - ie. syndynamics.org (the only google listed site that resembles Syn Dynamics Australia Pty Ltd) and you will find the message: \"We are currently working on our new site. webmaster@syndynamics.com. 9/4/ 2010 5:11 PM\". 2010? and the site has still yet to be created! Dot org domains can be bought for as little as $3 per year! I have looked high and low across the internet for \"Syn Dynamics Australia\" and I am convinced it does not exist. Yet it continues to be promoted on their website. Another company Chapmans bang on about on their wensite is 20FOUR Media Holdings Pty Limited. Closest domain I found was: http://www.20four.com.au/ : a blank page!  I recommend this company be investigated. Latest news is that because their shares have been 0.001 for the past month or so - they intend to consolidate them 10X, lest they be delisted. Also the Chapmans Ltd address you have listed on this site is their former address - supposedly their current address is:

Chapmans Limited
95 Pitt Street,
Level 12,
Sydney,
New South Wales, 2000,
Australia 

01/10/2018 15:27:56

Company Updates

Post your comments here

Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box. If an image appears, enter the word/figures you see in the image.

    loading Posting your comments. Please wait...

    Directors' on-market share transactions (last 5)

    rss feeds

    Purchases Sales

    DATEDIRECTORNATURENUMBERPRICEAMOUNT
    28/12/2017Peter Dykes5,800,000$0.010$58,000
    10/11/2017Muhamad Adlan bin Berhan40,050,000$0.005$200,250
    20/10/2017Peter Dykes1,700,000$0.005$8,500
    11/10/2017Peter Dykes1,000,000$0.005$5,000
    09/10/2017Peter Dykes6,000,000$0.005$30,193

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    NAMETITLEDATE OF APPT
    Peter DykesExecutive Chairman08/06/2012
    Colin TurnerNon Exec Director20/09/2018
    Adam MonaghanNon Exec Director20/09/2018
    Muhamad Adlan bin BerhanNon Exec Director11/08/2017

    Date of first appointment, title may have changed.

    Directors & Executives (former)

    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION
    Daler FayzievNon Exec Director03/07/201815/11/2018
    Anthony DunlopExecutive Director04/11/201315/11/2018
    Chris NewportNon Exec Director29/05/201511/05/2018
    Craig SeymourNon Exec Director19/02/201529/05/2015
    Bruce BurrellNon Exec Director01/05/201324/04/2015
    Robert CrossmanNon Exec Director31/05/201304/11/2013
    John HoustonNon Exec Director24/09/201217/06/2013
    Karen SkeltonNon Exec Director01/01/198617/06/2013
    Boris GankeNon Exec Chairman01/01/197431/05/2013
    Peter HethertonNon Exec Director01/01/198324/09/2012
    Evelyn GohNon Exec Director01/01/198524/09/2012
    Timothy ColemanNon Exec Director23/11/201131/05/2012

    Date of first appointment, title may have changed.